LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Morgan Stanley reiterates Nvidia as a top pick ahead of earnings

Chaim Potok by Chaim Potok
August 14, 2023
in Investing
Morgan Stanley reiterates Nvidia as a top pick ahead of earnings
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Despite the recent sell-off, Morgan Stanley remains confident in Nvidia in the long run. Analyst Joseph Moore reiterated his $500 price target on the chipmaker, implying the stock stands to gain 22.4% from Friday’s price. “With a backdrop of the massive shift in spending towards AI, and a fairly exceptional supply demand imbalance that should persist for the next several quarters; we think the recent selloff is a good entry point,” Moore wrote in a Monday note. The firm expects a “healthy upside” to Nvidia’s revenue, Moore said, adding that the company’s guidance for $4 billion last quarter was the largest single increase in one quarter in semiconductor history. “It seems clear that the implied $7.5 billion in quarterly data center revenue is trending to $15 billion+ over the next few quarters, which is our primary focus driving enthusiasm for the stock,” the analyst wrote. Much of the current supply chain shortage will likely resolve by the second half of 2024, he said. Shares of Nvidia have plunged nearly 10.2% this month, chipping away at its more than 185% gains this year — which have beaten every other member of the S & P 500. The company’s second-quarter results are due Aug. 23 after the closing bell. Moore anticipates $500 million to $1 billion of revenue upside to guidance for the July quarter, bringing the quarterly revenue to $11.5 billion to $12 billion. Nvidia recently surged past a $1 trillion market cap, making it the fifth-most valuable U.S. company. The analyst expects much of the company’s growth over the next five years to come from Nvidia’s datacenter division, as enthusiasm for generative AI supports growth for AI/machine learning hardware solutions. OpenAI’s viral chatbot, ChatGPT — as well as other AI models from few well-financed startups — all run on Nvidia’s graphics processing units. “The bottom line is that this is a very positive situation, October numbers are entirely gated by supply, and the upper end of the buy side consensus has been reined in,” Moore wrote. — CNBC’s Michael Bloom contributed reporting.



Source link

You might also like

Stay away from Goldman Sachs after monster rally this year, Citizens says

Analysts have been raising their earnings estimates on these stocks reporting this week

Here are Monday’s biggest analyst calls: Nvidia, Tesla, Rivian, Best Buy, Taiwan Semiconductor, Coinbase & more

Share30Tweet19
Previous Post

Jim Cramer’s top 10 things to watch in the stock market Monday

Next Post

Harmony Biosciences to buy Zynerba Pharmaceuticals for up to $200 million

Chaim Potok

Chaim Potok

Recommended For You

Stay away from Goldman Sachs after monster rally this year, Citizens says
Investing

Stay away from Goldman Sachs after monster rally this year, Citizens says

July 14, 2025
Analysts have been raising their earnings estimates on these stocks reporting this week
Investing

Analysts have been raising their earnings estimates on these stocks reporting this week

July 14, 2025
Here are Monday’s biggest analyst calls: Nvidia, Tesla, Rivian, Best Buy, Taiwan Semiconductor, Coinbase & more
Investing

Here are Monday’s biggest analyst calls: Nvidia, Tesla, Rivian, Best Buy, Taiwan Semiconductor, Coinbase & more

July 14, 2025
Evercore ISI downgrades Procter & Gamble as it loses market share on Amazon
Investing

Evercore ISI downgrades Procter & Gamble as it loses market share on Amazon

July 14, 2025
Next Post
Harmony Biosciences to buy Zynerba Pharmaceuticals for up to 0 million

Harmony Biosciences to buy Zynerba Pharmaceuticals for up to $200 million

Related News

First electric motorcycle maker signs on to Tesla’s NACS charging network

First electric motorcycle maker signs on to Tesla’s NACS charging network

June 29, 2023
How to watch Fury vs Ngannou in UK: Live stream, TV channel, PPV price

How to watch Fury vs Ngannou in UK: Live stream, TV channel, PPV price

October 28, 2023
US can’t rule out ‘Iran will get directly engaged’ and are preparing ‘for every possible contingency’

US can’t rule out ‘Iran will get directly engaged’ and are preparing ‘for every possible contingency’

October 16, 2023

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?